Vaccines

European Journal of Gastroenterology and Hepatology

Volumn 11, Issue SUPPL. 2, 1999, Pages

  Lee, Adrian ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Adjuvant; Animal model; Antigen; Cure; Helicobacter; Immunization; Infection; Vaccine development

Indexed keywords

VIRUS ANTIGEN; VIRUS VACCINE;

ANIMAL; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; IMMUNOLOGY; MOUSE; REVIEW; T LYMPHOCYTE SUBPOPULATION;

ANIMALS; ANTIGENS, VIRAL; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MICE; T-LYMPHOCYTE SUBSETS; VIRAL VACCINES;

EID: 0033176303     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-199908002-00016     Document Type: Review

References (41)

1. Yamada T, Ahnen D, Alpers DH, Greenberg HB, Gray M, Joscelyn KB, et al. Helicobacter pylori in peptic ulcer disease. JAMA 1994; 272:65-69.
2. Chen M, Lee A, Hazell SL. Immunisation against Helicobacter infection in a mouse/Helicobacter felis model. Lancet 1992; 339:1120-1121.
3. Czinn SJ, Cai A, Nedrud JG. Protection of germ-free mice from infection by Helicobacter felis after active oral or passive IgA immunization. Vaccine 1993; 11:637-642.
4. Michetti P, Corthesy-Theulaz I, Davin C, Haas R, Vaney AC, Heitz M, et al. Immunisation of BALB/c mice against Helicobacler felis infection with H. pylori urease. Gastroenterology 1994; 107:1002-1011.
5. Pappo J, Thomas WD, Kabok Z, Taylor NS, Murphy JC, Fox JG. Effect of oral immunization with recombinant urease on murine Helicobacter felis gastritis. Infect Immun 1995; 63:1246-1252.
6. Marchetti M, Arico B, Burroni D, Figura N, Rappuoli R, Ghiara P. Development of a mouse model of Helicobacter pylori infection that mimics human disease. Science 1995; 267:1655-1658.
7. Doidge C, Gust, Lee A, Buck F, Hazell S, Manne U. Therapeutic immunisation against Helicobacter infection. Lancet 1994; 343:914-915.
8. Corthesy-Theulaz I, Porta N, Glauser M, Saraga E, Vaney A-C, Haas R, et al. Oral immunization with Helicobacter pylori urease B subunit as a treatment against Helicobacter infection in mice. Gastroenterology 1995; 109:115-121.
9. Cuenca R, Blanchard TG, Czinn SJ, Nedrud JG, Monath TP, Lee CK, et al. Therapeutic immunization against Helicobacter mustelae in naturally infected ferrets. Gastroenterology 1996; 110:1770-1775.
10. Lee A. Therapeutic immunization against Helicobacter infection. Gastroenterology 1996; 110:2003-2006.
11. Labigne A, Cussac V, Courcoux P. Shuttle cloning and nucleotide sequences of Helicobacter pylori genes responsible for urease activity. J Bacteriol 1991; 173:1920-1931.
12. Mobley H, Island MD, Hausinger RP. Molecular biology of microbial ureases. Microbiol Rev 1995; 59:451-480.
13. Kreiss C, Buclin T, Cosma M, Corthesy-Theulaz I, Michetti P. Safety of oral immunisation with recombinant urease in patients with Helicobacter pylori infection. Lancet 1996; 347:1630-1631.
14. Michetti P, Kreiss C, Kotloff K, Porta N, Blanco JL, Bachmann D, et al. Oral immunization of H. pylori infected adults with recombinant urease and LT adjuvant. Gastroenterology 1997; 112:A1042.
15. Michetti P, Kreiss C, Kotloff KL, Porta N, Blanco JL, Bachmann D, et al. Oral immunization with urease and Escherichia coli heat-labile enterotoxin is safe and immunogenic in Helicobacter pylori-infected adults. Gastroenterology 1999; 116:804-812.
16. Ferrero RL, Thiberge JM, Kansau I, Wuscher N, Huerre M, Labigne A. The GroES homolog of Helicobacter pylori confers protective immunity against mucosal infection in mice. Proc Natl Acad Sci USA 1995; 92:6499-6503.
17. Webb E, Doidge C, Radcliff F, Lee A, Hocking D. Cloning potential protective antigens of Helicobacter pylori. Ir J Med Sci 1997; 166 (Suppl. 3):31.
18. Tomb JF, Sutton G, Glodek A. The complete DNA sequence of the Helicobacter pylori genome. Gut 1996; 39 (Suppl. 2):A3.
19. Dickinson BL, Clements JD. Dissociation of Escherichia coli heat-labile enterotoxin adjuvanticity from ADP-ribosyltranferase activity. Infect Immun 1995; 63:1617-1623.
20. Telford JL, Ghiara P. Prospects for the development of a vaccine against Helicobacter pylori. Drugs 1996; 52:799-804.
21. Ferrero RL, Thiberge J-M, Labigne A. Local immunoglobulin G antibodies, and not IgA, contribute to protective immunity against gastric H. felis infection in mice. Gut 1996; 39 (Suppl. 2)A44.
22. Ernst PB, Reves VE, Gourley WH, Häberle H, Bamford KB. Is the Th1/Th2 lymphocyte balance upset by Helicobacter pylori infection? In: Helicobacter pylori: Basic Mechanisms to Clinical Cure. Hunt RH, Tytgat GNJ (editors). Dordrecht, The Netherlands: Kluwer Academic Publishers; 1996. pp. 150-157.
23. Romagnani S. The biology of Th1 and Th2 cells. J Clin Immunol 1995; 15:121-129.
24. Romagnani S. Understanding the role of Th1/Th2 cells in infection. Trends Microbiol 1996; 4:470-473.
25. Karttunen R, Karttunen T, Ekre HPT, MacDonald TT. Interferon gamma and interleukin 4 secreting cells in the gastric antrum in Helicobacter pylori positive and negative gastritis. Gut1995; 36:341-345.
26. Karttunen RA, Karttunen TJ, Yousfi MM, el-Zimaity HM, Graham DY, el-Zaatari FA. Expression of mRNA for interferon-gamma, interleukin-10, and interieukin-12 (p40) in normal gastric mucosa and in mucosa infected with Helicobacter pylori. Scand J Gastroenterol 1997; 32:22-27.
27. Bamford KB. T-cell responses to Helicobacter pylori antigens. Ir J Med Sci 1997; 166 (Suppl. 3):3.
28. Bamford KB, O'Loughlin BO, Tham TCK, Collins JSA, Sloan JM, Watson RGP. Specific IgG subtype analysis indicates polarisation of the immune response in natural Helicobacter pylori infection. Ir J Med Sci 1997; 166 (Suppl. 3):20.
29. Del Prete G, D'Elios MM, Manghetti M, Romagnani S, Telford JL. H. pylori-specific Th1 effector cells in the gastric antrum of patients with peptic ulcer disease. Gut 1996; 39 (Suppl. 2):A42.
30. Mohammadi M, Czinn S, Redline R, Nedrud J. Adoptive transfer of Helicobacter-specific Th1 or Th2 cells exacerbates Helicobacter-associated gastritis, but only Th2 cells reduce the magnitude of infection. Gut 1996; 39 (Suppl. 2):A45.
31. Radcliff F, Ramsay AJ, Lee A. Failure of immunisation against Helicobacter infection in IL-4 mice: evidence for the Th2 immune response as the basis for protective immunity. Gastroenterology 1996; 110:A997.
32. Radcliff FJ, Ramsey AJ, Lee A. A mixed Th1/Th2 response may be necessary for effective immunity against Helicobacter. In: 9th International Congress of Mucosal Immunology. Sydney, Australia. 1997; A90.
33. Mohammadi M, Czinn S, Redline R, Nedrud J. Helicobacter-specific cell-mediated immune responses display a predominant Th1 phenotype and promote a delayed-type hypersensitivity response in the stomachs of mice. J Immunol 1996; 156:4729-4738.
34. Sakagami T, Dixon M, O'Rourke J, Hewlett R, Alderuccio F, Vella J, et al. Atrophic gastric changes in both Helicobacter felis and Helicobacter pylori infected mice are host dependent and separate from antral gastritis. Gut 1996; 39:639-648.
35. Mitchell HM, Li YY, Hu PJ, Liu Q, Chen M, Du GG, et al. Epidemiology of Helicobacter pylori in Southern China - identification of early childhood as the critical period for acquisition. J Infect Dis 1992; 166:149-153.
36. Corthesy-Theulaz I, Ferrero RL. Vaccines. Curr Opin Gastroenterol 1996; 12 (Suppl. 1):41-44.
37. Ferrero RL, Labigne A. Strategies for an oral vaccine against Helicobacter pylori. Curr Opin Gastroenterol 1996; 12:564-568.
38. Ghiara P, Michetti P. Development of a vaccine. Curr Opin Gastroenterol 1995; 11 (Suppl. 1):52-56.
39. Michetti P, Wadström T, Kraehenbuhl JP, Lee A, Kreiss C, Blum AL. Frontiers in Helicobacter pylori research - pathogenesis, host response, vaccine development and new therapeutic approaches. Eur J Gastroenterol Hepatol 1996; 8:717-722.
40. Nedrud JG, Czinn SJ. Helicobacter pylori. Curr Opin Gastroenterol 1997; 13:71-78.
41. Lee A, Buck F. Vaccination and mucosal responses to Helicobacter pylori infection. Aliment Pharmacol Ther 1996; 10 (Suppl. 1):129-138.